Display options
Share it on

Biologics. 2008 Sep;2(3):583-91. doi: 10.2147/btt.s3188.

IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts.

Biologics : targets & therapy

Mathieu C Tamby, Amélie Servettaz, Nicolas Tamas, Joseph Reinbolt, Frédéric Caux, Olivier Meyer, Yannick Allanore, André Kahan, Loïc Guillevin, Luc Mouthon

Affiliations

  1. Paris-Descartes University, Faculty of Medicine, UPRES-EA 4058, Paris, France;

PMID: 19707389 PMCID: PMC2721369 DOI: 10.2147/btt.s3188

Abstract

By using a semi-quantitative immunoblotting technique, we have analyzed serum immunoglobulin G (IgG) reactivities of patients with limited cutaneous systemic sclerosis and anticentromere antibodies, patients with diffuse systemic sclerosis and antitopoisomerase 1 antibodies, patients with diffuse systemic sclerosis without antitopoisomerase 1 or anticentromere antibodies and age- and gender-matched healthy controls with normal human skin fibroblasts and HEp-2 cells antigens. Serum IgG reactivities of patients with diffuse systemic sclerosis and antitopoisomerase 1 antibodies differed significantly from those of healthy controls or systemic sclerosis patients in other groups for reactivity with fibroblast proteins. IgG from patients with antitopoisomerase 1 antibodies bound to a 90 kDa fibroblast band and to a 100 kDa protein band in a HEp-2 cell protein extract. These two bands were further identified as DNA topoisomerase 1. Our results indicate that IgG from patients with diffuse systemic sclerosis bind DNA topoisomerase 1 in normal human fibroblasts extracts.

Keywords: DNA topoisomerase 1; IgG; autoantibodies; fibroblast; systemic sclerosis

References

  1. Arthritis Rheum. 2004 Oct;50(10):3265-74 - PubMed
  2. Ann Rheum Dis. 2003 Nov;62(11):1088-93 - PubMed
  3. Comp Biochem Physiol B Biochem Mol Biol. 1997 Oct;118(2):403-10 - PubMed
  4. Presse Med. 2006 Dec;35(12 Pt 2):1903-15 - PubMed
  5. Clin Immunol. 2004 Jun;111(3):241-51 - PubMed
  6. Clin Immunol. 2003 Nov;109(2):165-78 - PubMed
  7. J Rheumatol. 1988 Oct;15(10):1499-502 - PubMed
  8. N Engl J Med. 1998 Apr 23;338(17):1186-91 - PubMed
  9. Arthritis Rheum. 2002 Jun;46(6):1595-601 - PubMed
  10. Eur J Immunol. 1993 Nov;23(11):2851-9 - PubMed
  11. J Immunol. 1999 Jul 15;163(2):1066-72 - PubMed
  12. Scand J Immunol. 1996 Sep;44(3):243-51 - PubMed
  13. Thorax. 2005 Sep;60(9):765-72 - PubMed
  14. Br J Rheumatol. 1998 Jan;37(1):15-20 - PubMed
  15. Curr Rheumatol Rep. 2002 Apr;4(2):136-42 - PubMed
  16. N Engl J Med. 2006 Jun 22;354(25):2667-76 - PubMed
  17. Clin Exp Immunol. 2000 Jan;119(1):203-9 - PubMed
  18. J Rheumatol. 1988 Feb;15(2):202-5 - PubMed
  19. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3839-43 - PubMed
  20. J Clin Lab Immunol. 1982 May;8(1):9-12 - PubMed
  21. Arthritis Rheum. 1988 Mar;31(3):378-85 - PubMed
  22. Arthritis Rheum. 1988 Feb;31(2):196-203 - PubMed
  23. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1627-31 - PubMed
  24. Autoimmun Rev. 2003 May;2(3):152-7 - PubMed
  25. Autoimmunity. 1989;2(2):165-76 - PubMed
  26. Arthritis Rheum. 2000 Nov;43(11):2550-62 - PubMed
  27. Lancet. 1998 Feb 21;351(9102):559-62 - PubMed
  28. Arthritis Rheum. 2002 Jun;46(6):1602-13 - PubMed
  29. Clin Exp Immunol. 1989 Oct;78(1):26-30 - PubMed
  30. J Immunol. 2005 Oct 1;175(7):4555-60 - PubMed

Publication Types